Current position

Fidelity Investments’s Charles Riv Labs Intl Inc (CRL) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

FMR LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2018Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares4.24MHighest verified quarter-end share count
Quarters reported16Verified quarters with shares above zero
What happened?

FMR LLC first reported Charles Riv Labs Intl Inc in Q2 2018. The reported position was increased and reduced across later filings. FMR LLC currently reports 4.24M shares. The latest verified filing showed: Bought 22.7% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 22.7% more+783.51K shares · 4.24M shares reported after the change
Filing context

Quarter-end price $226.79

Q1 2026
Bought 99.3% more+1.72M shares · 3.46M shares reported after the change
Filing context

Quarter-end price $172.50

Q4 2025
Bought 319.3% more+1.32M shares · 1.73M shares reported after the change
Filing context

Quarter-end price $199.48

Q4 2023
Sold 58.1% of the position−526.07K shares · 379.29K shares remained
Filing context

Quarter-end price $236.40

Q3 2022
Sold 51.5% of the position−784.25K shares · 739.78K shares remained
Filing context

Quarter-end price $196.80

Q2 2022
Sold 36.2% of the position−864.79K shares · 1.52M shares remained
Filing context

Quarter-end price $213.97

Portfolio importance

How important is Charles Riv Labs Intl Inc in FMR LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#330of 5572 reported positions
Peak portfolio weight0.1%Q3 2021
Best historical rank#185Q3 2021
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$294.442026-09-24

Market context only; not an investor transaction price.

Latest filing quarter-end price$226.79Q2 2026

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

Coverage is bounded to Fidelity’s top reported positions and material events rather than every security in each Form 13F. The consolidated FMR LLC filing includes multiple Fidelity investment managers. Source filings may contain additional securities, and 13F filings do not reveal exact trade dates or execution prices.